Better Health for All

The provided articles, which include financial reports and sustainability summaries, do not contain specific, concrete data points relevant to the 'Better Health for All' ethical value. The company manufactures specialty chemicals,

and while some articles mention general sustainability efforts and ISO certifications for occupational health and safety (e.g., ISO 45001), these are explicitly excluded from the scope of this value. There is no information regarding the net health effect of the company's products on users, revenue from products with negative health outcomes, user safety records, price accessibility of health products, reach to vulnerable populations for health needs, transparency about health risks, investment in health innovation, indirect health externalities (excluding environmental pollution), health equity programs, healthcare workforce support, preventative health measures, healthcare data responsibility, global health crisis response, mental health initiatives, pharmaceutical patent flexibility, nutrition and food safety, healthcare education, addiction mitigation, or clinical trial ethics. Therefore, no KPIs can be scored based on the available evidence.

Fair Money & Economic Opportunity

H+R KGAA is a global manufacturer and supplier of specialty chemicals, not a financial institution.

Therefore, all KPIs related to lending, deposit services, financial products, or financial inclusion are not applicable to its core business. The company does not offer consumer credit products, manage customer finance data, or operate financial service access points. While the company engages in social commitments, such as supporting the Landmann Foundation with €12,000 annually for scholarships, this is not considered community finance reinvestment or financial inclusion initiatives as defined by the rubric for financial services.

Fair Pay & Worker Respect

The company's Lost Time Injury Frequency (LTIF) rate, which measures workplace accidents with at least one day lost per one million working hours, was 3.0 in 2024.

The overall Group voluntary employee turnover rate was 6.3% in 2024, a decrease from 4.3% in 2023. In terms of labor violations, the company reported 60 confirmed violations of its Social and Labor Standards Policy in 2023, 68 in 2022, and 41 in 2021. Additionally, 71 incidents of discrimination were reported in 2023.

Honest & Fair Business

H&R GmbH & Co. KGaA (2HRA.F) has a 'None' controversy level according to Sustainalytics data as of July 2025.

The company states it includes disclosures on material, non-financial aspects of business activities, including the fight against corruption, since 2017, but no specific policy details are provided.

Kind to Animals

The company's animal testing policy adheres to the 3Rs (Replacement, Reduction, Refinement, and Responsibility) principle, with strict ethics and welfare standards enforced on internal and external partners, except where mandated by critical safety regulations.

However, the company used almost 145,000 animals in testing in 2023, with 97% being rodents. For supplier audits, 66% of relevant suppliers were covered by a valid sustainability assessment in 2023, but the scope of these assessments regarding animal welfare is not specified. The company participates in initiatives like IMI 2 eTRANSAFE and collaborates with regulators to reduce animal use. It is also a member of the joint pharmaceutical industry Marseille Declaration, which advocates for worldwide implementation of high ethical and animal welfare standards.

Planet-Friendly Business

In 2024, H+R KGAA sourced approximately 54% of its electricity mix from renewable energies.

The company reported zero environmental compliance violations for both 2023 and 2024. H+R KGAA has set a target for carbon-neutral production by 2050. The company's emissions and carbon footprint calculator fulfills the requirements of a “cradle to gate” life cycle approach. In 2024, the total share of capital expenditure aligned with the EU Sustainable Taxonomy was 2.71%, combining investments for the PtL plant (0.01%), company cars (0.9%), solar power systems (0.2%), and buildings (1.6%). The company communicates its Code of Conduct to suppliers and checks for ISO 14001 certification and CO2 reduction strategies, but does not disclose specific supplier emissions. The company uses paraffins to weatherproof domestic timber, which it states renders the deforestation of tropical forests unnecessary, but lacks a formal deforestation policy.

Respect for Cultures & Communities

The provided articles do not contain specific, concrete data points or facts related to H+R KGAA's respect for cultures and communities.

The company's Annual Report 2023 explicitly notes a "Lack of specific data on community engagement, cultural impact assessments, and related metrics." Other articles are either about a different company (Merck) or discuss general HR/DE&I metrics without providing company-specific information for H+R KGAA. Therefore, no KPIs can be scored based on the evidence provided.

Zero Waste & Sustainable Products

The company reported a 69.2% circularity rate in 2024, which includes waste and avoided waste, excluding waste-to-energy.

97.7% of packaging in 2024 is considered recyclable, based on procurement data and technical feasibility. However, only 5.7% of materials used in 2024 were secondary reused or recycled components. In 2024, 115,326 metric tons of waste (hazardous and non-hazardous) were diverted from disposal, while 27,320 metric tons of hazardous waste were directed to disposal by incineration. The expected durability of Healthcare products was 3.1 years in 2024. Repairability was 51.0% in Life Science and 100.0% in Electronics, with Healthcare products excluded. Waste audits are recommended every 3-5 years. The company targets a 70% circularity rate by 2030. The Supplier Code of Conduct includes expectations for suppliers to address resource use and circular economy principles. No waste disposal violations were mentioned in the provided reports for the past three years.